CD4 and neoplasm: Our findings revealed that anti-tumor immune cells comprised activated CD4 T cells, effector memory CD4 T cells, and type 17 T helper cells, while intermediate immunocytes included activated B cells, eosinophils, immature B cells, mast cells, and memory B cells.